Latest Headlines

Latest Headlines

J&J's $2.5B-plus metal hip settlement offer approaches April 1 deadline

Patients have until April 1 to decide whether to sign on to the $2.5 billion-plus agreement Johnson & Johnson proposed last November to resolve 8,000 patient lawsuits involving defective all-metal hip implants. It's not clear yet whether the conglomerate will draw in enough people so the settlement can move forward.

UPDATED: J&J acknowledges $2.5B-plus hip lawsuit settlement agreement

Johnson & Johnson has confirmed an agreement to fork over at least $2.5 billion to settle thousands of lawsuits alleging injuries caused by defective all-metal hip implants. A large majority of eligible plaintiffs reportedly must support the agreement for it to go forward, and legions of legal cases not included in the deal will remain in play.

Does J&J's latest metal hip lawsuit boost the number to 10,001?

With more than 10,000 lawsuits already in the mix, Johnson & Johnson must deal with yet another patient's allegation's that company knowingly sold faulty metal hip implants and didn't warn the public.

J&J will abandon metal hip replacement sales

Johnson & Johnson has had enough with metal-on-metal and ceramic-on-metal hips, disclosing that it will leave those business lines entirely behind by the end of 2014.

UPDATED: For J&J, a hip lawsuit trial victory

After losing two jury trials, Johnson & Johnson/DePuy can now celebrate the fact that a jury has ruled in its favor regarding the company's ASR all metal hip implant.

J&J pressured to settle Australian hip lawsuits

Johnson & Johnson's $8.3 million defeat in a U.S. jury trial over its ASR metal-on-metal hip implant could force it to settle a massive class action lawsuit in Australia over the same product.

J&J metal hip problems keep erupting in the trenches

As if 8,000-plus lawsuits alleging faulty all metal helps weren't enough, Johnson & Johnson/DePuy data from an Illinois hospital suggests that repeat surgeries for patients dealing with the implants keep rising.

J&J's internal docs say recalled hip was defective

A Johnson & Johnson executive testified that the company recalled its all-metal hip replacements because they didn't meet "clinical expectations," not because they were defective, but that doesn't quite jibe with internal documents.

Witness: J&J lowered own standards to deem metal hips 'safe'

When Johnson & Johnson's metal-on-metal hip implants failed an internal safety test, the company opted against fixing the issue and instead just changed its protocols, a witness testified in one of thousands of lawsuits the drug and device giant now faces.

Report: J&J knew of hip failure years before recall

Johnson & Johnson was aware of the alarming failure rates of ASR hip implants a year before the company stopped making them and two years before they were recalled.